176 related articles for article (PubMed ID: 9636587)
1. Metabolic findings after liver transplantation within a randomised trial with or without steroids.
Tisone G; Angelico M; Vennarecci G; Palmieri G; Buonomo O; Negrini S; Casciani CU
Transplant Proc; 1998 Jun; 30(4):1447-8. PubMed ID: 9636587
[No Abstract] [Full Text] [Related]
2. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
[No Abstract] [Full Text] [Related]
3. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
Lladó L; Figueras J; Ramos E; Baliellas C; Torras J; Rafecas A; Fabregat J; Lama C; Ibañez L; Jaurrieta E
Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
[No Abstract] [Full Text] [Related]
4. Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy.
De Carlis L; Belli LS; Colella G; Rondinara GF; Slim AO; Alberti A; Aseni P; Sansalone CV; Pirotta V; Di Benedetto F; Forti D
Transplant Proc; 1999; 31(1-2):391-3. PubMed ID: 10083156
[No Abstract] [Full Text] [Related]
5. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy.
Jonas S; Guckelberger O; Tullius SG; Steinmüller T; Müller AR; Grauhan O; Langrehr JM; Bechstein WO; Neuhaus P
Transplant Proc; 2001 May; 33(3):2232-3. PubMed ID: 11377511
[No Abstract] [Full Text] [Related]
6. Neoral-based immunosuppression in living-related donor liver transplantation.
Liu PP; Chen CL; Chen YS; Wang CC; Chiang YC; Goto S; Cheng YF; Huang TL; Eng HL; Cheung HK; Jawan B
Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
[No Abstract] [Full Text] [Related]
7. Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
Klar E; Theilmann L; Hoffmann V; Hofmann W; Kraus T; Mehrabi A; Herfarth C
Transplant Proc; 1998 Nov; 30(7):3567-9. PubMed ID: 9838562
[No Abstract] [Full Text] [Related]
8. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
9. Low incidence of acute cellular rejection in liver transplantation with Neoral.
Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
[No Abstract] [Full Text] [Related]
10. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
[No Abstract] [Full Text] [Related]
11. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
[No Abstract] [Full Text] [Related]
12. Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance.
Minguela A; Torío A; Marín L; Sánchez-Bueno F; García-Alonso AM; Ontañón J; Parrilla P; Alvarez-López MR
Transplant Proc; 1999; 31(1-2):519-20. PubMed ID: 10083217
[No Abstract] [Full Text] [Related]
13. Acute cardiac ongoing rejection: comparison between different strategies.
Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
[No Abstract] [Full Text] [Related]
14. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
[No Abstract] [Full Text] [Related]
15. Weaning of immunosuppression in liver transplant recipients.
Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
[TBL] [Abstract][Full Text] [Related]
16. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
17. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
18. Does initial graft function influence the outcome after liver transplantation?
Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
[No Abstract] [Full Text] [Related]
19. Long-term immunosuppression after liver transplantation: are steroids necessary?
Padbury RT; Gunson BK; Dousset B; Hubscher SG; Mayer AD; Buckels JA; Neuberger JM; Elias E; McMaster P
Transpl Int; 1992; 5 Suppl 1():S470-2. PubMed ID: 14621849
[TBL] [Abstract][Full Text] [Related]
20. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
